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Toll-like receptors (TLRs), a family of pattern-
recognition receptors that detect conserved 
molecular products of microorganisms, have 
been shown to play an essential role in the in-
duction of immune responses (1). Recognition 
of microbial products by TLR expressed on 
“classic” innate cells, such as dendritic cells, trig-
gers their maturation leading to initiation of 
antigen-specifi  c adaptive immune responses 
through T cell activation. Furthermore, direct 
signals through TLRs expressed on B cells play an 
important role in the activation and optimal an-
tibody production to T-dependent antigens (2).
However, adaptive immune responses take 
days to weeks to fully develop, which is too 
much of delay to combat quickly replicating 
microorganisms. To facilitate prompt antibody 
responses, a special subset of B cells, marginal 
zone (MZ) B and B1 cells, appears to be evo-
lutionarily selected and maintained (3). These 
cells, named innate-like B cells (4, 5), bridge 
the innate and adaptive immunity and make 
an optimal transition between the two immune 
responses by producing the fi  rst wave of anti-
bodies required for antigenic clearance. Indeed, 
B1 cells are known to participate in a very early 
T-independent phase of immune responses 
against bacteria, viruses, and certain parasites 
(6–12). This characteristic is partly explained 
by their lower threshold than conventional B2 
cells for activation, proliferation, and diff  eren-
tiation into plasma cells. Besides functional 
characteristics, B1 cells are distinguished from 
conventional B (B2) cells by their anatomical 
location, self-renewing capacity, and surface 
phenotype (13–15). B1 cells are located mainly 
in the peritoneal and pleural cavities and ex-
press high levels of surface IgM and low levels 
of IgD, CD23, and B220. In addition to Mac-1, 
a signifi   cant fraction of peritoneal B1 cells, 
known as B1a cells, expresses CD5, whereas 
the remaining fraction constitutes B1b cells.
Multiple studies on B1 cells have been fo-
cusing on developmental origins, repertoire se-
lection, and activation requirements of this 
subset of cells compared with conventional B2 
cells. However, despite the importance of B1 
cells in protection from infections, surprisingly 
little is known about how these cells are re-
tained in the body cavities and even less is un-
derstood about the molecular signals required 
for their recruitment out of their compartment 
for antigenic clearance.
Molecules that are universally involved in 
cell adhesion are integrins. These are heterodi-
meric (αβ) transmembrane glycoproteins essential 
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for many fundamental processes, like self-renewal and diff  er-
entiation of hematopoietic cells, cell migration, and tissue re-
tention (16–18). They bind cellular receptors, such as vascular 
cell adhesion molecule 1 or intercellular adhesion molecule 
1, and extracellular matrix components, such as laminin or 
fi  bronectin. Some integrins physically associate with small 
proteins called tetraspanins (19) that were also implicated in 
a broad range of biological activities, including cell fusion, 
motility, metastasis, proliferation, and diff  erentiation (20, 21). 
For example, CD9 plays a critical role in sperm–egg fusion 
(22) and a reverse correlation of CD9 expression and cancer 
metastasis is well documented (21, 23, 24). Interestingly, ex-
pression of CD9 on B cells is restricted to innate-like cells 
such as B1 and MZ B cells as well as plasma cells (25).
Besides integrins and their associating partners, chemo-
kines and chemokine receptors are known to play important 
roles for cell migration and localization (26). They are not 
only participating in the recruitment of cells into the lym-
phoid tissues, but also, as revealed in recent studies, in the 
egress of cells from these lymphoid tissues (27).
Here we show that B1 cells express extremely high levels 
of integrins and that direct signals through TLRs induce a 
massive egress of B1 cells from the peritoneal cavity that is 
associated with coordinated down-regulation of integrins and 
CD9. We have also demonstrated that modulation of adhe-
sion/motility-related proteins on B1 cells allows them to mi-
grate with enhanced motility in response to chemokines. 
Our studies have thus identifi  ed key requirements for mobi-
lization of nonrecirculating cells and established a role for 
TLRs in control of B1 cell egress.
RESULTS
Bacteria and bacterial components induce B1 cell egress
One function of peritoneal B1 cells is to survey the abdomi-
nal cavity and to join forces with innate cells, such as macro-
phages (MΦ), for a rapid and effi   cient bacterial clearance. We 
mimicked an acute infection from the gut by administration 
of high doses of indomethacin, an antiinfl  ammatory drug that 
disrupts the gut epithelial barrier (28). Translocation of bacte-
ria, predominantly from the small intestine (as indicated by 
16SrRNA sequences, with Lactobacillus being the predomi-
nant bacteria in the small intestine in our mouse colony) into 
the peritoneum-associated tissues (omentum and mesente-
rium; Fig. 1 A) induced dramatic changes in the cellular com-
position of the peritoneal cavity. These changes consisted of a 
depletion of resident B1 cells and a massive infl  ux of mono-
cytes/MΦ or granulocytes from the blood (Fig. 1, B and C). 
To monitor the kinetics of B1 cell egress from the peritoneal 
cavity, we injected fl  uorescence-labeled live bacteria i.p. We 
found that 3 h after injection, similar percentages and num-
bers of B cells (B220+IgM+) and MΦ (B220−IgM−) were 
loaded with bacteria (Fig. 1 D). However, 6 h after peritoni-
tis, the number of bacteria+ B cells as well as the total number 
of B1 cells (B220lowIgMhi Mac-1+) present in the perito-
neal cavity drastically decreased, whereas the number of 
B220−Mac-1+ cells containing bacteria increased (Fig. 1 E).
A similar egress of B1 cells from the peritoneal cavity was 
not only associated with bacteria phagocytosis, but also with 
cell stimulation by pure bacterial components. As shown in 
Fig. 1 F, i.p. injection of lipid A induced a signifi  cant deple-
tion of B1 cells from the peritoneal cavity. We suspected that 
the omentum, an entry site for B1 cells (29), might also rep-
resent an exit route. In agreement with this, we found that at 
3 and 5 h after lipid A stimulation the numbers of B1 cells in 
the omentum increased, which were probably in transit out 
from the peritoneal cavity (Fig. 1 F). Target organs for B1 
cell migration outside the peritoneum-associated tissues were 
evaluated 14 h after i.p. injection of GFP+ peritoneal cells 
into RAG2−/− mice. Stimulation with lipid A or peptidogly-
can by i.p injection induced a signifi  cant increase in the num-
bers of B1 cells that migrated to the spleen or small intestine 
lamina propria (Fig. 1 G and not depicted). Thus, the pres-
ence of bacteria or bacterial components in the abdominal 
cavity drives a large fraction of B1 cells out of the peritoneal 
cavity and thereby facilitates their migration to eff  ector sites.
Impaired egress of B1 cells from TLR4−/− mice
We next asked if the egress of peritoneal B1 cells induced by 
lipid A or peptidoglycan required direct signals through TLRs. 
The migration properties of peritoneal B1 cells isolated from 
TLR4−/− mice were compared with those from normal mice 
in competitive transfer experiments after stimulation with lipid 
A. Although equal numbers of B1 cells from GFP transgenic 
(Tg) and TLR4−/− mice were injected into the peritoneal cav-
ity of RAG2−/− mice, much less TLR4−/−-derived B1 cells 
could be detected outside the peritoneal cavity 14 h after trans-
fer (Fig. 1 H). The majority of B1 cells that migrated to the 
omentum, mesenterium, spleen, or small intestine were de-
rived from GFP Tg mice, and their homing index was three to 
four times higher as compared with that of B1 derived from 
TLR4−/− mice (Fig. 1 I). To ensure that TLR4−/− B1 cells 
were not innately defi  cient in their ability to home to periph-
eral tissues, we performed competitive transfer experiments in 
the absence of stimulation. As shown in Fig. 1 H, similar per-
centages of B1 cells from GFP Tg and TLR4−/− mice could 
be detected outside the peritoneal cavity, clearly indicating that 
the impaired egress of TLR4-defi  cient B1 cells after acute stim-
ulation was due to their unresponsiveness to TLR ligands.
The results demonstrate that signals through TLRs on B1 
cells are responsible for a rapid and effi   cient mobilization of B1 
cells from the peritoneal cavity to other lymphoid organs.
TLR stimulation induces integrin down-regulation 
on B1 cells
We next wanted to elucidate the mechanisms involved in 
TLR-induced B1 cell egress. We found that peritoneal B1 
cells express much higher levels of α4, α6, and β1 integrins 
as compared with freely recirculating spleen B2 cells (Fig. 2 A). 
This observation raised the possibility that a high expression 
level of integrins is responsible for retention of B1 cells in the 
peritoneal cavity and would make pertinent the prediction 
that TLR-induced egress involves integrin down-regulation JEM VOL. 203, October 30, 2006  2543
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on B1 cells. Indeed, analyses of integrin levels after LPS stim-
ulation revealed a striking and selective down-regulation of 
surface integrins on B1 cells (Fig. 2 B). Stimulation with LPS i.p. 
reduced the mean fl  uorescence intensity level of α4, α6, and 
β1 integrins on B1 cells to <50% by 6 h after injection, in 
parallel with cell activation, as assessed by CD69 expression 
Figure 1.  Bacteria and bacterial components induce peritoneal B1 
cell egress. (A) Bacteria identifi  ed by sequence analyses of the 16S rRNA 
genes in omentum (OM) and mesenterium (MES) after s.c. injection of 
indomethacin. Each color represents a specifi  c sequence, and the numbers 
indicate percentages in sequenced clones. (B) Representative fl  ow cyto-
metric profi  les of peritoneal cavity cells in control (Indo−) or mice treated 
24 h previously with indomethacin (Indo+). Numbers indicate the per-
centages of B1 cells (IgMhiMac-1+) and monocytes-MΦ (IgM−Mac-1hi) in 
total cells. (C) Absolute numbers of B1 cells and monocytes-MΦ in the 
peritoneal cavity before and 24 h after indomethacin treatment. (D) Rep-
resentative fl  ow cytometric profi  les and (E) total numbers of 
B220+DsRed+(B cells) and B220−DsRed+(MΦ) of cells from the perito-
neal cavity 3 and 6 h after i.p. injection of 107 E. coli (DH5α) expressing 
Ds-Red. (F) Total numbers of B220lowIgMhi Mac-1+ B1 cells from the peri-
toneal cavity and omentum at the indicated time points after i.p. injection 
of 10 μg lipid A. Mean ± standard error, n = 4, Student’s t test. (G) Total 
numbers of B1 cells in the peritoneal cavity (PEC), spleen (SPL), and small 
intestine (SI) 14 h after i.p. injection of 107 peritoneal cells from GFP Tg 
mice without (white bars) or with 10 μg lipid A (black bars). Mean ± 
standard error, n = 5, Mann-Whitney test. Competitive homing experi-
ments between peritoneal B1 cells from GFP Tg mice (WT) and TLR-4−/− 
mice. (H) Percentages of B220lowGFP+ (white bars) and B220lowGFP− (black 
bars) B1 cells in the IgM+ gate, and (I) the homing index calculated by 
total B1 numbers in the indicated tissues 14 h after i.p. injection of peri-
toneal cells (1:1 ratio) into RAG2−/− mice together with 10 μg lipid A. 
Error bars represent 95% confi  dence intervals. Data are representative of 
two independent experiments.2544  B1 CELLS EGRESS FROM THE PERITONEAL CAVITY | Ha et al.
(Fig. 2 B). In contrast, it did not aff  ect the expression level of 
Mac-1 (αM) on B1 cells nor of any integrins expressed on 
spleen B2 cells (Fig. 2 B). i.v. injection of LPS, although 
strongly activated spleen B2 cells, as assessed by CD69 
up-regulation, failed to induce changes of integrin levels, 
whereas B1 cells responded by a similar down-regulation as 
seen after i.p. challenge (Fig. S1 A, available at http://www.
jem.org/cgi/content/full/jem.20061041/DC1). It is therefore 
unlikely that the nonresponsiveness of spleen B2 cells is attrib-
uted to a lack of suffi   cient activation by LPS injection i.p.
Integrin modulation on B1 cells was the consequence of 
direct signaling through TLRs and not of engagement of B 
cell receptors because injection of lipid A had no eff  ect on 
peritoneal cells from TLR4−/− mice, whereas it induced a 
clear integrin down-regulation in WT mice (Fig. 2 C). We 
further investigated whether the adaptor molecule myeloid 
diff   erentiation primary response gene 88 (MyD88) was 
critical for TLR-dependent down-modulation of surface in-
tegrins on B1 cells. Consistent with complete MyD88 de-
pendency for TLR2 but not TLR4 signaling described for 
Figure 2.  TLR stimulation induces integrin down-regulation on B1 
cells. (A) Representative fl  ow cytometric profi  les of cells isolated from the 
peritoneal cavity (PEC) and spleen (SPL) stained for IgM and the indicated 
integrins. Gates were set for PEC B1 (red) and SPL B2 (black). (B) Kinetics 
of surface integrin modulation on peritoneal B220lowIgMhi Mac-1+ B1 
cells (red squares) and spleen (SPL) B220+IgM+ cells (black squares) after 
i.p. stimulation with 20 μg LPS. Mean ± standard error, n = 3 mice. 
(C) Representative fl  ow cytometric profi  les of peritoneal cavity cells 
stained for IgM and α4 and β1 integrins isolated from WT and TLR-4−/− 
mice 5 h after i.p injection of PBS or 10 μg lipid A. Histograms show 
mean fl  uorescence intensities of surface integrins on IgMhi Mac-1+ B1 
cells (red gate) without (black line) and with (red line) stimulation. 
(D) Mean fl  uorescence intensities of α4, α6, and β1 integrins and CD9 of 
peritoneal B1 cells from MyD88−/− mice and WT mice 5 h after i.p. injec-
tion of PBS (white bars), 1 μg PAM2CSK4 (black bars), or 10 μg lipid A 
(red bars). Mean ± standard error, n = 3 mice, Student’s t test.JEM VOL. 203, October 30, 2006  2545
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other aspects of innate and adaptive immune responses 
(30–34), we found that MyD88−/− mice did not respond to 
synthetic TLR2 ligand (Pam2CSK4) but clearly down-regulated 
integrins on peritoneal B1 cells after TLR4 ligand (lipid A) 
stimulation (Fig. 2 D). We further confi  rmed that integrin 
down-modulation on peritoneal B1 cells was a direct eff  ect 
of TLRs on B cells (rather than an indirect one through cy-
tokines secreted by activated peritoneal MΦ) because puri-
fi  ed B cells stimulated in vitro had an identical response with 
those from nonsorted cultures (Fig. S1 B).
Coordinated regulation of integrin and CD9 through TLRs
To further prove the involvement of integrins in B1 cell mi-
gration, we examined the eff  ect of blocking integrin function 
with antibodies. Thus, we performed short-term transfer ex-
periments with peritoneal cells preincubated in vitro with in-
tegrin-blocking antibodies in the absence of any stimulation. 
Anti-α4 antibody treatment resulted in a modest decrease in 
B1 cell number in the peritoneal cavity and a slight increase 
in B1 cells that migrated to the spleen (Fig. 3 A). Similar re-
sults were obtained when peritoneal cells were preincubated 
with a combination of anti-α4, α6, and β1 antibodies (not 
depicted). Thus, down-modulation of integrins alone cannot 
explain the effi   cient egress of peritoneal B1 cells seen after 
TLR stimulation.
CD9 is known to be selectively expressed by B1 cells (25) 
and to regulate cell motility (20). We found that CD9 ex-
pression on the surface of peritoneal B1 cells is correlative 
with α6 and β1 although not with α4 integrins (Fig. 3 B). 
These observations led us to examine if TLR stimulation in-
duces modifi  cations in CD9 expression that can be related 
with B1 cell migration out of the peritoneal cavity or perito-
neum-associated tissues. As shown in Fig. 3 (C and D), i.p. 
stimulation with LPS induced a considerable down-regula-
tion of CD9 expression on B1 cells 5 h after activation in WT 
mice but not in TLR2,4−/− mice. LPS-induced CD9 changes 
on B1 cells paralleled modulation of α4, α6, and β1 integrin 
expression, including a coordinated up-regulation 14 h after 
stimulation (Fig. 3 D). Furthermore, similar to α4, α6, and 
β1 integrins, CD9 down-regulation after TLR4 stimulation 
with lipid A was MyD88 independent, whereas that induced 
through TLR2 after PAM2CSK4 stimulation was dependent 
on MyD88 (Fig. 2 D). Strikingly, in vitro preincubation of 
peritoneal cells with both anti-α4 and anti-CD9 antibodies 
induced a signifi  cant depletion of B1 cells from the peritoneal 
cavity and a parallel increase in the number of B1 cells that 
migrated to the omentum, mesenterium, or spleen 3 h after 
transfer (Fig. 3 A). Anti-CD9 antibody treatment alone ex-
erted a strong eff  ect on peritoneal cell migration, with in-
creased numbers of B1 cells being either in transit or already 
homed to the spleen.
The enhanced egress of B1 cells observed after CD9 
blocking was not due to the down-regulation of surface 
integrins (not depicted) but most likely to increased cell 
motility. This is based on the observations that both anti-
CD9 antibody–treated cells or peritoneal cells from CD9−/− 
mice migrated much faster than control or WT cells on 
  fi  bronectin-coated microchannels in response to CXCL13 
(Fig. 3, E and F, and Videos S1 and S2, which are available 
at http://www.jem.org/cgi/content/full/jem.20061041/DC1). 
To further confi  rm a direct involvement of CD9 in B1 cell 
migration, we performed in vivo competitive transfer experi-
ments between normal and CD9−/− B1 cells. Cells (1:1 ratio 
of CD9−/−/GFP Tg B1) were preincubated in vitro with 
anti-α4 alone or anti-α4 and anti-CD9 antibodies, and B1 
cell migration was evaluated 3 h after injection into the peri-
toneal cavity of RAG2−/− mice. As shown in Fig. 3 G, the 
majority of B1 cells that migrated to the spleen after integrin 
α4 blocking were derived from CD9−/− mice. In contrast, 
similar percentages of CD9−/− and GFP B1 cells were de-
tected in the spleen after preincubation with both anti-α4 
and anti-CD9 antibodies. This result clearly indicates that 
anti-CD9 antibodies enhanced the migration of B1 cells from 
GFP Tg mice by blocking the CD9 function, and that modu-
lation of integrins and CD9 together is required to induce B1 
cell mobilization. Thus, coordinated integrin-CD9 down-
regulations induced by TLR stimulation cause effi   cient emi-
gration of B1 cells from the peritoneal cavity.
G protein–coupled receptors are required for B1 cell egress
Because the B1 cell migration under steady-state conditions 
was shown to require intact signaling through chemokine re-
ceptors (35), we next inquired if chemokines and their recep-
tors are also involved in B1 cell egress induced by TLR 
stimulation. Therefore, we tested the eff  ect of pertussis toxin 
(PTX) treatment on the TLR-induced egress of B1 cells. 
Peritoneal cavity cells were incubated in vitro for 2 h with 
PTX, an enzyme that ADP ribosylates and inactivates Gαi 
proteins, or, as a control, with the non-ADP–ribosylating 
oligomer B subunit of PTX, and then transferred into the 
peritoneal cavity of RAG2−/− mice with lipid A. As shown 
in Fig. 4 A, PTX treatment caused a substantial ( 85–90%) 
inhibition of B1 cell migration to the omentum, mesente-
rium, and spleen, with their accumulation in the peritoneal 
cavity 8 h after cell transfer.
Several lymphoid chemokines were constitutively pro-
duced by omentum and mesothelial cells of the peritoneal 
wall (Fig. 4 B). Among these, the most abundantly expressed 
were CXCL13 and CCL19, and these were also the only 
chemokines of which we detected up-regulation at mRNA 
levels after stimulation (Fig. 4 B). Furthermore, CXCL13-
producing cells were mainly located in the lymphoid aggre-
gates of omentum (Fig. 4 C), and B1 cells showed robust 
chemotactic response to CXCL13, both in vivo and in vitro 
(29, 35–37). Consistent with published results (29), except 
for the CXCL13, the mRNA levels for CXCL12, CCL19, 
and CCL21 were very low to undetectable in peritoneal 
MΦ. To determine the contribution of omentum-derived 
CXCL13 for emigration of peritoneal B1 cells, an equal 
number of GFP+ peritoneal cells were injected without or 
with lipid A into the peritoneal cavity of WT and CXCL13−/− 
mice. The effi   ciency of GFP+ B1 cell egress was evaluated 14 h 2546  B1 CELLS EGRESS FROM THE PERITONEAL CAVITY | Ha et al.
after the transfer. As shown in Fig. 4 D, fewer B1 cells mi-
grated after lipid A stimulation to the omentum in CXCL13−/− 
mice than in WT mice, and the number of GFP+ B1 cells re-
covered from the peritoneal cavity of CXCL13−/− mice was 
signifi  cantly higher than the number of B1 cells recovered 
from WT mice. In contrast, similar numbers of B1 cells were 
recovered from the peritoneal cavity of both CXCL13−/− 
and WT mice in the absence of stimulation (Fig. 4 D). 
CCR7-CCL19 receptor–ligand pair might also be involved 
in peritoneal B1 cell egress because CCR7−/− B1 cells tend 
Figure 3.  Egress of B1 cells requires coordinated down-regulation 
of integrins and CD9. (A) Total number of B220lowIgMhi B1 cells recov-
ered from the peritoneal cavity (PEC), omentum (OM), mesenterium (MES), 
and spleen (SPL) 3 h after i.p. injection (without any TLR stimulation) into 
RAG-2−/− mice of peritoneal cells preincubated for 20 min with the indi-
cated blocking antibodies. Mean ± standard error, n = 4–7, Student’s t 
test. (B) CD9 and integrin α4, α6, and β1 fl  ow cytometric profi  les of IgM+ 
gated peritoneal cavity cells. (C) Representative IgM and CD9 profi  les of 
B220+ gated peritoneal cavity cells 5 h after i.p. injection of PBS or 20 μg 
LPS. Numbers indicate the mean fl  uorescence intensity of CD9 in gated 
cells. (D) Kinetics of surface expression of CD9 (red line), integrin α4 
(blue line), α6 (orange line), and β1 (black line) in WT mice (squares) and 
TLR-2,4−/− mice (circles) after i.p. injection of 20 μg LPS. (E) Frequency 
distribution of peritoneal cell velocities toward CXCL13 after incubation with 
isotype control or 200 μg/ml anti-CD9 antibodies at the 15-min time 
point. p-value was measured by Student’s t test. (F) Velocity of peritoneal 
cells from WT mice (black) or CD9−/− mice (red) determined by measuring 
cell displacements with successive video frames (1 min) during 50-min 
chemotaxis. Data represent the mean ± standard error of a minimum of 
40 cells tracked for each time point and cell phenotype. (G) Competitive 
migration between peritoneal B1 cells from GFP Tg mice (WT) and CD9−/− 
mice. B1 cells (1:1 ratio) were preincubated for 30 min with anti-α4 or 
anti-α4 and 200 μg/ml anti-CD9 antibodies and injected i.p. into 
RAG2−/− mice. Percentages of GFP+ (black bars) and GFP− (white bars) 
cells in the B220lowIgMhi gate from the indicated tissues 3 h after injec-
tion. Error bars represent 95% confi  dence intervals, n = 2 mice/group.JEM VOL. 203, October 30, 2006  2547
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to accumulate more than WT B1 cells in the peritoneal cav-
ity after transfer into RAG2−/− mice (Fig. S2 A, available at 
http://www.jem.org/cgi/content/full/jem.20061041/DC1) 
and CCR7−/− mice accumulate much more peritoneal cells 
as compared with WT mice (38 and unpublished data). Col-
lectively, these results clearly indicate that G protein–coupled 
receptors are required for TLR-induced peritoneal B1 cell 
egress and that CXCL13 is an important chemokine involved 
in this emigration process.
DISCUSSION
We demonstrate here that independent from antigenic rec-
ognition through specifi   c B cell receptors, direct signals 
through TLRs induce B1 cell egress from the peritoneal cavity. 
The sensing of bacteria or bacterial components triggers a 
series of coordinated events on B1 cells, consisting of rapid, 
transient, and parallel down-regulation of integrins and CD9. 
These changes are required for B1 cell egress because the lack 
of integrin-CD9 down-modulation is associated with a sig-
nifi  cant impairment in B1 cell egress in TLR4−/− mice after 
lipid A stimulation (Fig. 1 H). Involvement of integrins and 
CD9 on regulation of retention versus migration of perito-
neal B1 cells was confi  rmed by antibody treatment as well as 
in competitive migration studies with WT and CD9- defi  cient 
B1 cells (Fig. 3, A and G). Furthermore, peritoneal B1 
cells appear to use similar molecular machinery with classic 
innate cells to transduce signals from TLRs. Thus, the TLR4 
signaling cascade involves both MyD88-dependent and 
-independent pathways, whereas signals through TLR2 are 
strictly dependent on MyD88 function (Fig. 2, C and D).
Figure 4.  Involvement of chemokine and chemokine receptors for 
B1 cell egress. (A) Total number of IgMhiMac1+B1 cells recovered from 
the peritoneal cavity (PEC), omentum (OM), mesenterium (MES), and 
spleen (SPL) of RAG2−/− mice 8 h after i.p. injection (with 10 μg lipid A) 
of peritoneal cells treated for 2 h with 100 ng/ml oligomer B (white bars) 
or PTX (black bars). Mean ± standard error, n = 2. (B) Quantitative PCR 
analyses of the indicated chemokines in omentum (OM), mesothelial cells 
(Meso), and peritoneal MΦ (PEC MΦ) expressed as relative amounts of 
mRNA normalized to 36B4. Bars represent the mean ± standard error of 
three experiments. (C) Whole mount pictures of omentum stained for 
CXCL13 and lymphatic endothelium marker (Lyve-1). Bar, 50 μm. (D) Total 
numbers of B1 cells in the peritoneal cavity (PEC) and omentum (OM) 
14 h after i.p. injection of 107 peritoneal cells from GFP Tg mice without 
or with 10 μg lipid A into WT mice (white bars) or CXCL13−/− mice (black 
bars). Mean ± standard error, n = 3, Student’s t test.2548  B1 CELLS EGRESS FROM THE PERITONEAL CAVITY | Ha et al.
Besides changes in integrin-CD9 expression, the exit of 
B1 cells from their compartment requires chemokine recep-
tors. This is clearly demonstrated by the fact that treatment 
with PTX almost completely inhibits migration out of peri-
toneal B1 cells, even under activation conditions. CXCR5-
CXCL13 appears to be the receptor–ligand pair used by B1 
cells not only for homing into the peritoneum, but also for 
their egress out of the peritoneal cavity. This conclusion is 
supported by the observation that a much larger fraction of 
B1 cells (injected directly into the peritoneal cavity, thus cir-
cumventing the involvement of CXCL13 for homing) re-
mained in the peritoneal cavity of CXCL13−/− mice than in 
WT mice, even after stimulation through TLR (Fig. 4 D).
The responsiveness to CXCL13, abundantly produced in 
the omentum, appears to be infl  uenced by modulation of 
CD9 because CD9-blocked peritoneal cells as well as those 
from CD9−/− mice migrated both faster and more effi   ciently 
to CXCL13 (Videos S1 and S2, and Fig. 3, E and F).
Sphingosine-1-phosphate receptor 1 (S1P1) was shown to 
be involved in lymphocyte egress from the lymphoid organs 
(39). Peritoneal B1 cells express S1P1 and show a moderate 
chemotactic response to S1P1 ligand (S1P) under nonacti-
vated conditions (Fig. S2, B and C). However, after TLR 
stimulation, both S1P1 expression and the chemotactic re-
sponse of B1 cells to S1P decreased (Fig. S2, B and C), mak-
ing it unlikely that S1P1-S1P plays a signifi   cant role for 
peritoneal B1 cell egress.
TLR signals may control B1 cell recruitment and partici-
pation not only in acute responses, but also in steady-state 
conditions for the maintenance of immune system homeosta-
sis. Indeed, we found that germ-free mice accumulate signifi  -
cantly more numbers of B1 cells in the peritoneal cavity or 
peritoneum-associated tissues compared with mice kept un-
der specifi  c pathogen-free conditions harboring a diverse gut 
microbiota (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20061041/DC1). We speculate that a sig-
nifi  cant fraction of B1 cells that survey the abdominal cavity 
are sensing the gut microbiota and are constantly induced 
to migrate out of the peritoneal cavity. They are likely 
to participate in maintenance of homeostasis of the gut 
barrier by producing secretory IgAs against commensal bacteria. 
The B1-derived IgAs are generated through a primitive T-
independent and follicular-independent pathway and play an 
important role in the regulation of bacterial communities in 
the intestine (40–43). Our fi  ndings fully support the conclusion 
that B1 cells are innate-like B cells with specialized functions 
that are poised to react rapidly to gut-associated antigens and 
pathogens (3).
Thus, the egress of B1 cells from the peritoneal cavity is a 
complex, multistep process governed by interplay between 
integrins, tetraspanins, and chemokines that would allow 
these innate-like B cells to coordinate effi   cient immune re-
sponses against infections.
The results presented here reveal an unexpected require-
ment for TLR signaling in the down-modulation of integrin 
and tetraspanin expression on innate-like B1 cells, which is 
critical for their rapid mobilization and participation in im-
mune responses. TLRs are thus involved in the control of 
antibody responses in multiple steps: activation and recruit-
ment of B1 cells to eff  ector sites of immune responses; relo-
calization of splenic MZ B cells from the MZ to white pulp 
cords (6, 44, 45); and proliferation and diff  erentiation of B1 
MZ B cells into antibody-secreting cells (6). These sequential 
TLR-orchestrated events lead to effi   cient removal of patho-
gens soon after infection and facilitate optimal transition from 
innate to adaptive immune responses.
MATERIALS AND METHODS
Mice and adoptive cell transfers. Mice, all on a C57BL/6 background, 
were bred and maintained in specifi  c pathogen-free conditions at the animal 
facility of the Research Center for Allergy and Immunology and used at 8–16 
wk of age. Germ-free mice were obtained from Yakult. For cell transfer, WT, 
RAG2−/−, and CXCL13−/− mice were injected i.p. with 107 peritoneal cells 
obtained from age- and sex-matched GFP Tg mice. For competitive transfer 
experiments, peritoneal cavity cells obtained from GFP Tg mice and TLR4−/− 
or CD9−/− mice were counted, stained for surface markers, mixed to a 1:1 
  ratio of B1 cells ( 106 B220lowIgMhi cells), and injected into RAG2−/− mice. 
All animal experiments were performed in accordance with approved   protocols 
from the Institutional Animal Care at RIKEN.
Stimulation with TLR ligands. Mice were stimulated with lipid A and 
endotoxin-free PAM2CSK4, both purchased from InvivoGen, and LPS 
(Escherichia coli O26:B6) from Sigma-Aldrich. For bacteria-induced peritoni-
tis, the E. coli DH5α strain was transformed with pGex-4T-1 (GE Health-
care) vector expressing DsRed2 (original vector pDsRed2 was from 
CLONTECH Laboratories, Inc.). After 10–12 h of aerobic growth at 37°C, 
the cultures were maintained overnight under micro-aerophilic conditions 
at room temperature. After this period, 70–80% of the bacteria expressed 
detectable levels of DsRed2. After two washes with PBS, DsRed2+ bacteria 
were quantifi   ed using a fl   uorescence microscope (Axioplan2; Carl Zeiss 
  MicroImaging, Inc.), and 1–10 × 107 fl  uorescent units were injected into mice 
i.p. For disruption of the gut barrier, 10-wk-old BALB/c mice (Clea) were 
subcutaneously injected twice at 12-h intervals with 25 mg/kg indometha-
cin (Sigma-Aldrich). Mice were killed and analyzed after 1 d. DNA was ex-
tracted from cell suspensions obtained after the digestion of omentum and 
mesenterium, and the 16S rRNA was amplifi  ed by universal primers de-
scribed previously (43).
Cell preparation and antibodies. Peritoneal cells, spleen, and mesenteric 
lymph node cell suspensions were prepared as described previously (35). 
Cells from parietal peritoneum, omentum, mesenterium, and small intestine 
lamina propria were isolated after stirring for 45 min with 1.5 mg/ml colla-
genase (Wako) and 0.5 U/ml dispase at 37°C. Cells were washed twice in 
RPMI medium with 2% FCS and stained for fl  ow cytometry. Allophycocy-
anin (APC) anti-B220 (RA3-6B2), PE anti-CD49d (integrin α4, R1-2), PE 
anti-CD49f (integrin α6, GoR3), biotin anti-CD29 (integrin β1, Ha2-5), 
biotin anti-CD9 (KMC8), and FITC anti-CD21 were from BD Biosciences. 
APC anti-CD11b (Mac-1) and PE anti-CD69 (H1.2F3) were from eBiosci-
ence, and FITC or PE anti-IgM was from SouthernBiotech.
Cell sorting and in vitro cultures. Peritoneal B1 cells (B220lowIgMhiMac-1+) 
and spleen B cells (B220hiIgM+) were sorted, (FACSAria; Becton Dickinson) 
or run through the nozzle without sorting, after staining with APC anti-
B220, FITC anti-IgM, and PE anti–Mac-1. Cells were incubated with RPMI 
medium supplemented with 10% FCS and 20 μM 2-ME without or with 
20 μg/ml LPS. After 12 h, cells were recovered, washed, and stained for 
surface integrins.
Blocking experiments. For integrin or/and CD9 blocking, cells were 
treated before i.p. injection for 20–30 min with 100 μg/ml of purifi  ed JEM VOL. 203, October 30, 2006  2549
ARTICLE
  anti-integrin α4 antibody (clone R1-2) and 200 μg/ml anti-CD9 antibody 
(clone KMC8). All antibodies were obtained from BD Biosciences. For G 
protein inactivation, peritoneal cells were treated with 100 ng/ml oligomer 
B or PTX (Sigma-Aldrich) for 2 h in RPMI medium supplemented with 
10% FCS and 20 μM 2-ME, washed, and injected i.p. into RAG-2−/− mice 
together with 10 μg lipid A.
Whole mount microscopy. Omenta were dissected from animals, placed 
in 24-well plates, fi  xed with Cytofi  x/Cytoperm solution (BD Biosciences) 
for 30 min at 4°C, and incubated for 60 min with the following antibodies: 
goat IgG anti–mouse CXCL13 (R&D Systems), rabbit IgG anti–Lyve-1 
(Abcam), FITC-conjugated donkey anti–goat IgG (H+L), and Cy3-
  conjugated donkey anti–rabbit IgG (Jackson ImmunoResearch  Laboratories). 
Stained tissues were placed on slides, mounted (Vectashield; Vector Labora-
tories), and analyzed with a confocal laser-scanning microscope (model 
DMRXA2; Leica).
Chemotaxis assays and locomotion analysis. The KK chamber (Ef-
fector Cell Institute) was used to detect real-time chemotaxis of peritoneal 
lymphocytes (46). Peritoneal cells were incubated in the RPMI media with 
10% FCS for 1.5 h at 37°C to remove the MΦ, harvested, and incubated 
for an additional 20 min with 200 μg/ml anti-CD9 (KMC8) or isotype 
control antibodies. Cells were washed in warm RPMI 1640, 2% FCS, and 
10 mM Hepes, and then loaded (1 μl of 106 cells/ml) into the top wells. 
CXCL13 (PeproTech) was loaded into the bottom well (10 μg/ml). The 
micro cover glass was coated with 40 μg/ml fi  bronectin (Biogenesis). A 
charge-coupled device camera was used to record the migration of perito-
neal B cells for 1.5 h at 37°C. The migration velocity of peritoneal lym-
phocytes on the KK chamber was analyzed using Volocity software 
(Improvision Inc.). Frames of video images were captured and digitized by 
the computer. To measure the cell displacement, the screen x and y coor-
dinates of individual cells were tracked over the time, followed by the cal-
culation of cell velocity. For each sample,  40 cells were tracked over a 
30-min period. The frame-by-frame velocity data were used to calculate 
the mean velocity and the variance of velocity. Chemotactic response to 
S1P (Sigma-Aldrich) was performed using Transwell membranes as de-
scribed previously (35).
RT-qPCR. Total RNA was isolated from cells using the RNeasy mini-kit 
(QIAGEN). After the spectrometric analysis, equal amounts of RNA were 
used for cDNA synthesis. After DNase treatment, oligo dT primers were used 
for fi  rst-strand cDNA synthesis (RT). All procedures were performed accord-
ing to the manufacturer’s instructions (Invitrogen). Quantitative PCR was 
performed on an iCycler thermal cycler using SYBR Green Supermix accord-
ing to instructions and analyzed by software (all Bio-Rad Laboratories). All 
primers were determined by BEACON DESIGNER (v2.1; Premier Biosoft 
International). Sequences were as follows: 36B4 forward: 5′-C  A  C  T  G  G  T  C-
T  A  G  G  A  C  C  C  G  A  G  A  A  G  , reverse: 5′-G  G  T  G  C  C  T  C  T  G  G  A  G  A  T  T  T  T  C  G  ; 
CXCL13 forward: 5′-T  G  A  A  G  T  T  G  T  G  A  T  C  T  G  G  A  C  C  A  A  G  A  , reverse: 
5′-A  C  A  G  A  C  T  T  T  T  G  C  T  T  T  G  G  A  C  A  T  G  T  C  ; CXCL12 forward: 5′-A  A  G  G-
T  C  G  T  C  G  C  C  G  T  G  C  T  G  , reverse: 5′-G  A  T  G  C  T  T  G  A  C  G  T  T  G  G  C  T  C  T  G  G  ; 
CCL21 forward: 5′-G  G  C  T  A  T  A  G  G  A  A  G  C  A  A  G  A  A  C  C  A  A  G  T  , reverse: 
5′-T  C  C  T  C  A  G  G  G  T  T  T  G  C  A  C  A  T  A  G  C  T  ; CCL19 forward: 5′-C  C  T  G  G-
G  A  A  C  A  T  C  G  T  G  A  A  A  G  C  , reverse: 5′-G  C  A  C  A  G  A  G  C  T  G  A  T  A  G  C  C  C  C-
T  T  A  ; and S1P1 forward: 5′-T  T  C  C  G  C  A  A  G  A  A  C  A  T  C  T  C  C  A  A  G  G  , reverse: 
5′-C  A  G  C  C  C  A  C  A  T  C  T  A  A  C  A  G  T  A  G  T  A  G  G  .
Starting quantity of cDNA was 800 ng RNA for omentum and meso-
thelial cell samples. Optimized fi  nal primer concentrations ranged from 150 
to 300 nM, and reactions were run for 3 min at 95°C, followed by 40 cycles 
of 15 s at 95°C, 20 s at 60°C, 20 s at 72°C, and one cycle of 1 min at 95°C. 
A serially diluted positive control (bulk cDNA) and RT minus controls of 
each tested sample were included in each PCR reaction. Specifi  city of PCR 
products was initially confi  rmed by sequence analysis and subsequently by 
melt-curve analysis. All qPCR reactions were repeated three times with dif-
ferent preparations of cDNA.
Online supplemental material. Fig. S1 shows the down-regulation of in-
tegrin α4 and β1 on peritoneal B1 cells after in vivo (i.v.) and in vitro LPS 
stimulation. Fig. S2 shows possible involvement of CCR7 but not S1P1 for 
B1 cell egress from the peritoneal cavity. Fig. S3 presents the total B1 cell 
numbers in the peritoneal cavity and omentum in germ-free and specifi  c 
pathogen-free mice. Videos S1 and S2 show real-time chemotaxis to 
CXCL13 of peritoneal B cells from WT and CD9−/− mice, respectively. 
The online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20061041/DC1.
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